Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SYK Stryker Corp
- Stocks
- Healthcare
- NYSE: SYK
Price (delayed)
$377.3
Market cap
$144.19B
P/E Ratio
50.31
Dividend/share
$3.28
EPS
$7.5
Enterprise value
$158.65B
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems;
Highlights
The company's revenue rose by 11% YoY and by 2.8% QoQ
Stryker's gross profit has increased by 11% YoY and by 2.8% QoQ
SYK's debt is up by 30% YoY and by 23% from the previous quarter
SYK's quick ratio is down by 28% from the previous quarter and by 6% YoY
Key stats
What are the main financial stats of SYK
Market
Valuations
Earnings
Shares outstanding
382.16M
Market cap
$144.19B
Enterprise value
$158.65B
Price to earnings (P/E)
50.31
Price to book (P/B)
6.88
Price to sales (P/S)
6.2
EV/EBIT
47.6
EV/EBITDA
42.22
EV/Sales
6.83
Revenue
$23.22B
Gross profit
$14.85B
Operating income
$3.55B
Net income
$2.86B
EBIT
$3.33B
EBITDA
$3.76B
Free cash flow
$3.58B
Per share
Balance sheet
Liquidity
EPS
$7.5
EPS diluted
$7.4
Free cash flow per share
$9.37
Book value per share
$54.85
Revenue per share
$60.83
TBVPS
$54.45
Total assets
$46.01B
Total liabilities
$25.08B
Debt
$16.78B
Equity
$20.93B
Working capital
$5.09B
Debt to equity
0.8
Current ratio
1.64
Quick ratio
0.8
Net debt/EBITDA
3.85
Margins
Efficiency
Dividend
EBITDA margin
16.2%
Gross margin
64%
Net margin
12.3%
Operating margin
15.3%
Return on assets
6.7%
Return on equity
14%
Return on invested capital
13.1%
Return on capital employed
8.8%
Return on sales
14.4%
Dividend yield
0.87%
DPS
$3.28
Payout ratio
43.7%
SYK stock price
How has the Stryker stock price performed over time
Intraday
-0.84%
1 week
-1.72%
1 month
-2.64%
1 year
9.99%
YTD
4.79%
QTD
1.36%
Financial performance
How have Stryker's revenue and profit performed over time
Revenue
$23.22B
Gross profit
$14.85B
Operating income
$3.55B
Net income
$2.86B
Gross margin
64%
Net margin
12.3%
SYK's net margin is down by 23% YoY and by 7% from the previous quarter
Stryker's operating margin has decreased by 22% YoY and by 6% QoQ
SYK's net income is down by 15% year-on-year and by 4.5% since the previous quarter
The operating income has declined by 14% year-on-year and by 3.7% since the previous quarter
Price vs fundamentals
How does SYK's price correlate with its fundamentals
Growth
What is Stryker's growth rate over time
Valuation
What is Stryker stock price valuation
P/E
50.31
P/B
6.88
P/S
6.2
EV/EBIT
47.6
EV/EBITDA
42.22
EV/Sales
6.83
SYK's P/E is 18% above its last 4 quarters average of 42.8 and 14% above its 5-year quarterly average of 44.3
Stryker's EPS has decreased by 15% YoY and by 4.6% from the previous quarter
SYK's P/B is 9% above its 5-year quarterly average of 6.3 and 2.7% above its last 4 quarters average of 6.7
SYK's equity is up by 9% year-on-year
The company's revenue rose by 11% YoY and by 2.8% QoQ
The stock's price to sales (P/S) is 9% more than its 5-year quarterly average of 5.7
Efficiency
How efficient is Stryker business performance
Stryker's ROIC has decreased by 26% YoY and by 8% from the previous quarter
The ROE fell by 24% YoY and by 7% QoQ
The ROA has contracted by 23% YoY and by 7% from the previous quarter
Stryker's ROS has decreased by 23% YoY and by 7% from the previous quarter
Dividends
What is SYK's dividend history
DPS
$3.28
Dividend yield
0.87%
Payout ratio
43.7%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Stryker financials performed over time
The total assets is 83% greater than the total liabilities
SYK's quick ratio is down by 28% from the previous quarter and by 6% YoY
Stryker's total liabilities has increased by 24% YoY and by 12% QoQ
SYK's debt is 20% less than its equity
SYK's debt is up by 30% YoY and by 23% from the previous quarter
The debt to equity has grown by 21% from the previous quarter and by 19% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.